Paclitaxel, Carboplatin, and Panitumumab in Treating Patients With Metastatic Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: panitumumab|DRUG: paclitaxel|DRUG: carboplatin|PROCEDURE: laboratory biomarker analysis|PROCEDURE: immunohistochemistry staining method
Sponsor: Wake Forest University Health Sciences